The overall mutation frequencies for CALR exon 9 mutations were 20.3% (25/123) in all MPN patients, 31.1% (23/74) in ET patients, 25.0% (1/4) in PMF patients, and 2.2% (1/45) in PV patients. The gene discussed is CALR; the disease is myeloproliferative disorder.